Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers.
Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers.
复制标题
DOI:
10.1371/journal.pone.0070630
复制
发表时间:
2013
期刊:
影响因子:
3.7
通讯作者:
O'Garra A
中科院分区:
文献类型:
--
作者:
Bloom CI;Graham CM;Berry MP;Rozakeas F;Redford PS;Wang Y;Xu Z;Wilkinson KA;Wilkinson RJ;Kendrick Y;Devouassoux G;Ferry T;Miyara M;Bouvry D;Valeyre D;Gorochov G;Blankenship D;Saadatian M;Vanhems P;Beynon H;Vancheeswaran R;Wickremasinghe M;Chaussabel D;Banchereau J;Pascual V;Ho LP;Lipman M;O'Garra A
New approaches to define factors underlying the immunopathogenesis of pulmonary diseases including sarcoidosis and tuberculosis are needed to develop new treatments and biomarkers. Comparing the blood transcriptional response of tuberculosis to other similar pulmonary diseases will advance knowledge of disease pathways and help distinguish diseases with similar clinical presentations. To determine the factors underlying the immunopathogenesis of the granulomatous diseases, sarcoidosis and tuberculosis, by comparing the blood transcriptional responses in these and other pulmonary diseases. We compared whole blood genome-wide transcriptional profiles in pulmonary sarcoidosis, pulmonary tuberculosis, to community acquired pneumonia and primary lung cancer and healthy controls, before and after treatment, and in purified leucocyte populations. An Interferon-inducible neutrophil-driven blood transcriptional signature was present in both sarcoidosis and tuberculosis, with a higher abundance and expression in tuberculosis. Heterogeneity of the sarcoidosis signature correlated significantly with disease activity. Transcriptional profiles in pneumonia and lung cancer revealed an over-abundance of inflammatory transcripts. After successful treatment the transcriptional activity in tuberculosis and pneumonia patients was significantly reduced. However the glucocorticoid-responsive sarcoidosis patients showed a significant increase in transcriptional activity. 144-blood transcripts were able to distinguish tuberculosis from other lung diseases and controls. Tuberculosis and sarcoidosis revealed similar blood transcriptional profiles, dominated by interferon-inducible transcripts, while pneumonia and lung cancer showed distinct signatures, dominated by inflammatory genes. There were also significant differences between tuberculosis and sarcoidosis in the degree of their transcriptional activity, the heterogeneity of their profiles and their transcriptional response to treatment.
登录
查看更多内容
DOI:
10.1164/rccm.200912-1855oc
发表时间:
2010-06-15
影响因子:
24.7
作者:
Lockstone, Helen E.;Sanderson, Sharon;Ho, Ling-Pei
通讯作者:
Ho, Ling-Pei
影响因子:
64.8
作者:
通讯作者:
--
影响因子:
29.7
作者:
Cooper AM
通讯作者:
Cooper AM
影响因子:
25.7
作者:
Hoffmann, RM;Jung, MC;Pape, GR
通讯作者:
Pape, GR
DOI:
10.1164/ajrccm.164.10.2104046
发表时间:
2001-11-15
影响因子:
24.7
作者:
Baughman, RP;Teirstein, AS;Cherniak, R
通讯作者:
Cherniak, R